Relevant Journal Publications

2015

  1. Cannon T.D., Chung Y., He G., Sun D., Jacobson A., van Erp T.G., McEwen S., Addington J., Bearden C.E., Cadenhead K., Cornblatt B., Mathalon D.H., McGlashan T., Perkins D., Jeffries C., Seidman L.J., Tsuang M., Walker E., Woods S.W., Heinssen R. (2015) North American Prodrome Longitudinal Study Consortium. Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biological Psychiatry, 77(2):147-57. PMID:25034946   http://www.ncbi.nlm.nih.gov/pubmed/?term=25034946
  2. Kane J.M., Robinson D.G., Schooler N.R., Marcy P., Correll C.U., Brunette M.F., Mueser K.T., Rosenheck R.A., Addington J., Estroff S.E., Robinson J., Penn D.L., Severe J. (2015) The RAISE Early Treatment Program for first-episode psychosis: background, rationale and study design. Journal of Clinical Psychiatry, 76(3):240-6. PMID:25830446   http://www.ncbi.nlm.nih.gov/pubmed/?term=25830446
  3. Addington J., van der Gaag M. (2015) Psychosocial treatments for clinical high risk individuals. Schizophrenia Bulletin, 41(1):22. PMID:25316912   http://www.ncbi.nlm.nih.gov/pubmed/?term=25316912
  4. Perkins D.O., Jeffries C.D., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Mathalon D.H., McGlashan T.H., Seidman L.J., Tsuang M,T., Walker E.F., Woods S.W., Heinssen R. (2015) Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project. Schizophrenia Bulletin, 2015 Mar; 41(2):419-28. PMID:25103207   http://www.ncbi.nlm.nih.gov/pubmed/?term=25103207
  5. Piskulic D., Barbato M., Liu L., Addington J. (2015) Pilot study of cognitive remediation therapy on cognition in young people at clinical high risk of psychosis. Psychiatry Research, 225(1-2):93-8. PMID:25467705   http://www.ncbi.nlm.nih.gov/pubmed/?term=25467705
  6. Auther A.M., Cadenhead K.S., Carrión R.E., Addington J., Bearden C.E., Cannon T.D., McGlashan T.H., Perkins D.O., Seidman L., Tsuang M., Walker E.F., Woods S.W., Cornblatt B.A. (2015) Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample. Acta Psychiatrica Scandinavica, 2015 July; 132(1):60-8. PMID:25572323   http://www.ncbi.nlm.nih.gov/pubmed/?term=25572323
  7. Addington J., Heinssen R.K., Robinson D.G., Schooler N.R., Marcy P., Brunette M.F., Correll C.U., Estroff S., Mueser K.T., Penn D., Robinson J.A., Rosenheck R.A., Azrin S.T., Goldstein A.B., Severe J., Kane J.M.  (2015) Duration of Untreated Psychosis in Community Treatment Settings in the United States. Psychiatric Services, 2015 July 1; 66(7):753-6. PMID:25588418   http://www.ncbi.nlm.nih.gov/pubmed/?term=25588418
  8. Chung Y., Jacobson A., He G., van Erp T.G.M., McEwen S., Addington J., Bearden C.E., Cadenhead K., Cornblatt B., Mathalon D.H., McGlashan T., Perkins D., Seidman L.J., Tsuang M., Walker E., Woods S.W., Heinssen R., Cannon T.D. (2015). North American Prodrome Longitudinal Study (NAPLS) Consortium.  Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion among Clinically High-Risk Youth Developing Psychotic Disorders. Molecular Neuropsychiatry 2015; 1:13-22
  9. Anticevic A., Haut K., Murray J.D., Repovs G., Yang G.J., Cole M.W., McEwen S.C., Bearden C.D., Addington J., Goodyear B., Cadenhead K.S., Mirzakhanian H., Cornblatt B.A., Olvet D., Mathalon D.H., McGlashan T.H., Perkins D.O., Belger A., Seidman L.J., Thermenos H., Tsuang M.T., van Erp T.G.M., Walker E.F., Hamann S., Woods S.W., Qiu M., Cannon T.D. (In Press) Thalamic dysconnectivity is associated with conversion to psychosis in youth at elevated clinical risk. JAMA Psychiatry
  10. Mueser K.T., Penn D.L., Addington J., Brunette M.F., Gingerich S., Glynn S.M., Lynde D.W., Gottlieb J.D., Meyer-Kalos P., McGurk S.R., Cather C., Saade S., Robinson D.G., Schooler N.R., Rosenheck R.A., Kane J.M. (2015) The NAVIGATE Program for First-Episode Psychosis: Rationale, Overview, and Description of Psychosocial Components Psychiatric Services, 2015 July1; 66(7):680-90. PMID:25772766   http://www.ncbi.nlm.nih.gov/pubmed/?term=25772766
  11. Robinson D.G., Schooler N.R., John M., Correll C.U., Marcy P., Addington J., Brunette M.F., Estroff S.E., Mueser K.T., Penn D., Robinson J., Rosenheck R.A., Severe J., Goldstein A., Azrin S., Heinssen R., Kane J.M. (2015) Prescription Practices in the Treatment of First-Episode Schizophrenia Spectrum Disorders: Data from the National RAISE-ETP Study. American Journal of Psychiatry, 172(3):237-48. PMID:25727536   http://www.ncbi.nlm.nih.gov/pubmed/?term=25727536
  12. Gee D.G., McEwen S.C., Forsyth J.K., Haut K.M., Bearden C.E., Addington J., Goodyear B., Cadenhead K.S., Mirzakhanian H., Cornblatt B.A., Olvet D., Mathalon D.H., McGlashan T.H., Perkins D.O., Belger A., Seidman L.J., Thermenos H., Tsuang M.T., van Erp T.G., Walker E.F., Hamann S., Woods S.W., Constable T., Cannon T.D. (2015) Reliability of an fMRI paradigm for emotional processing in a multisite longitudinal study. Human Brain Mapping, 2015 Jul; 36(7):2558-79. PMID:25821147   http://www.ncbi.nlm.nih.gov/pubmed/?term=25821147
  13. Addington J., Liu L., Buchy L., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Bearden C.E., Mathalon D.H., McGlashan T.H. (2015) North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms. The Journal of Nervous and Mental Disease, 2015 May; 203(5):328-35. PMID:25919383   http://www.ncbi.nlm.nih.gov/pubmed/?term=25919383
  14. Stowkowy J., Liu L., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Bearden C.E., Mathalon D., Heinssen R., Addington J. (2015) Core Schemas in Youth at Clinical High Risk for Psychosis. Behavioural and Cognitive Psychotherapy, 2015 Apr; 21:1-11. PMID:25896713   http://www.ncbi.nlm.nih.gov/pubmed/?term=25896713
  15. Barbato M., Liu L.,  Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E., Woods S.W., Bearden C.E., Mathalon D.H., & Addington J. (in Press) Theory of mind, emotion recognition and social perception in individuals at clinical high risk of psychosis: Findings from the NAPLS 2 cohort. Schizophrenia Research: Cognition
  16. Waford R.N., MacDonald A., Goines K., Novacek D.M., Trotman H.D., Elaine F.W., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Heinssen R., Mathalon D.H., Tsuang M.T., Perkins D.O., Seidman L.J., Woods S.W., McGlashan T.H. (2015) Demographic correlates of attenuated positive psychotic symptoms. Schizophrenia Research, 2015 May 18; S0920-9964(15)00230-3. PMID:25999040 http://www.ncbi.nlm.nih.gov/pubmed/?term=25999040
  17. Buchy L., Stowkowy J., MacMaster F., Nyman K. & Addington J. (2015) Meta-cognition is associated with cortical thickness in youth at clinical high risk of psychosis. Psychiatry Research, 2015 Jul 15; S0925-4927(15)30033-0. PMID: 26210694   http://www.ncbi.nlm.nih.gov/pubmed/?term=26210694

2014

  1. Cannon T.D., Sun F., McEwen S.J., Papademetris X., He G., van Erp T.G., Jacobson A., Bearden C.E., Walker E., Hu X., Zhou L., Seidman L.J., Thermenos H.W., Cornblatt B., Olvet D.M., Perkins D., Belger A., Cadenhead K., Tsuang M., Mirzakhanian H., Addington J., Frayne R., Woods S.W., McGlashan T.H., Constable R.T., Qiu M., Mathalon D.H., Thompson P., Toga A.W. (2014) Reliability of neuroanatomical measurements in a multisite longitudinal study of youth at risk for psychosis. Human Brain Mapping, 2014 May; 35(5): 2424-34. PMID:23982962   http://www.ncbi.nlm.nih.gov/pubmed/?term=23982962
  2. Saleem M.M., Stowkowy J., Cadenhead K.S., Cannon T., Cornblatt B., McGlashan T., Perkins D., Seidman L., Tsuang M., Walker E., Woods S. & Addington J. (2014) Perceived Discrimination in those at Clinical High Risk for Psychosis. Early Intervention in Psychiatry,  2014 Feb; 8(1):77-81. PMID:23773288   http://www.ncbi.nlm.nih.gov/pubmed/?term=23773288
  3. Addington J., Case N., Saleem M.M., Auther A.M., Cornblatt B.A., Cadenhead K.S. (2014) Substance use in Clinical High Risk for psychosis – A review of the literature. Early Intervention in Psychiatry, 2014 May; 8(2):104-12. PMID:24224849   http://www.ncbi.nlm.nih.gov/pubmed/?term=24224849
  4. Meyer E.C., Carrión R.E., Cornblatt B.A., Addington J., Cadenhead K.S., Cannon T.D., McGlashan T.H., Perkins D.O., Tsuang M.T., Walker E.F., Woods S.W., Heinssen R., Seidman L.J., NAPLS Group (2014) The Relationship of Neurocognition and Negative Symptoms to Social and Role Functioning Over Time in Individuals at Clinical High Risk in the First Phase of the North American Prodrome Longitudinal Study. Schizophrenia Bulletin, 2014 Nov; 40(6):1452-61. PMID:24550526   http://www.ncbi.nlm.nih.gov/pubmed/?term=24550526
  5. Deighton S., Addington J. (2014) Exercise practices of young people at their first episode of psychosis. Schizophrenia Research, 2014 Jan; 152(1):311-2. PMID:24275584  http://www.ncbi.nlm.nih.gov/pubmed/?term=24275584
  6. Addington J., Shah H., Liu L., Addington D. (2014) Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis. Schizophrenia Research, 2014 Mar; 153(1-3):64-7. PMID:24439270   http://www.ncbi.nlm.nih.gov/pubmed/?term=24439270
  7. Lecomte T., Corbière M., Ehmann T., Addington J., Abdel-Baki A., MacEwan B. (2014) Development and Preliminary Validation of The First Episode Social Functioning Scale for Early Psychosis. Psychiatry Research, 2014 May 30; 216(3):412-7. PMID:24613006   http://www.ncbi.nlm.nih.gov/pubmed/?term=24613006
  8. Alderman T., Addington J., Bearden C., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Cadenhead K.S. (2014) Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium. Early Intervention Psychiatry, 2014 Feb 27; PMID:24576057 http://www.ncbi.nlm.nih.gov/pubmed/?term=24576057
  9. Yong E., Barbato M., Penn D.L., Keefe R.S.E., Woods S.W., Perkins D.O., Addington J. (2014) Exploratory analysis of social cognition and neurocognition in individuals at clinical high risk for psychosis. Psychiatry Research, 2014 Aug 15; 218(1-2):39-43. PMID:24755041 http://www.ncbi.nlm.nih.gov/pubmed/24755041
  10. Forsyth J.K., McEwen S.C., Gee D.G., Bearden C.E., Addington J., Goodyear B., Cadenhead K.S., Mirzakhanian H., Cornblatt B.A., Olvet D.M., Mathalon D.H., McGlashan T.H., Perkins D.O., Belger A., Seidman L.J., Thermenos H.W., Tsuang M.T., van Erp T.G., Walker E.F., Hamann S., Woods S.W., Qiu M., Cannon T.D. (2014) Reliability of functional magnetic resonance imaging activation during working memory in a multi-site study: Analysis from the North American Prodrome Longitudinal Study. Neuroimage, 2014 Aug 15; 97: 41-52. PMID:24736173   http://www.ncbi.nlm.nih.gov/pubmed/?term=24736173
  11. Miklowitz D.J., O'Brien M.P., Schlosser D.A., Addington J., Candan K.A., Marshall C.E., Domingues I., Walsh B.C., Zinberg J.L., De Silva S.D., Friedman-Yakoobian M.S., Cannon T.D. (2014) Family-Focused Treatment for Adolescents and Young Adults at High Risk for Psychosis: Results of a Randomized Trial. Journal of the American Academy of Child and Adolescent Psychiatry, 2014 Aug; 53(8): 848-58. PMID:25062592   http://www.ncbi.nlm.nih.gov/pubmed/?term=25062592
  12. Stowkowy J., Perkins D.O., Woods S.W., Nyman K., Addington J. (2014) Personal Beliefs about Experiences in those at Clinical High Risk for Psychosis. Behavioural and Cognitive Psychotherapy, 2014 Jun 20:1-7. PMID:24949991   http://www.ncbi.nlm.nih.gov/pubmed/?term=24949991
  13. Correll C.U., Robinson D.G.,  Schooler N.R., Brunette M.F., Mueser K.T., Rosenheck R.A.,  Marcy P., Addington J., Estroff S.E., Robinson J., Penn D., Azrin S., Goldstein A., Severe J., Heinssen R., Kane J.M. (2014) Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study. JAMA Psychiatry, 2014 Dec 1; 71(12):1350-1363. PMID:25321337   http://www.ncbi.nlm.nih.gov/pubmed/?term=25321337
  14. Marshall C., Denny E., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Addington J. (2014) The Content of Attenuated Psychotic Symptoms in Those at Clinical High Risk for Psychosis. Psychiatry Research, 2014 Nov 30; 219(3):506-12. PMID:25048759   http://www.ncbi.nlm.nih.gov/pubmed/?term=25048759
  15. Marulanda S., Addington J. (2014) Resilience in Individuals at Clinical High Risk for Psychosis. Early Intervention in Psychiatry, 2014 Sep 18. PMID:25234104   http://www.ncbi.nlm.nih.gov/pubmed/?term=25234104
  16. Woods S.W., Walsh B.C., Addington J., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Heinssen R., Perkins D.O., Seidman L.J., Tarbox S.I., Tsuang M.T., Walker E.F., McGlashan T.H. (2014) Current Status Specifiers for Patients at Clinical High Risk for Psychosis. Schizophrenia Research, 2014 Sep; 158(1-3):69-75. PMID:25012147   http://www.ncbi.nlm.nih.gov/pubmed/?term=25012147
  17. Buchy L., Perkins D., Woods S.W., Liu L., Addington J. (2014) Impact of substance use on conversion to psychosis in youth at clinical high risk of psychosis. Schizophrenia Research, 2014 Jul; 156(2-3):277-80. PMID:24837058   http://www.ncbi.nlm.nih.gov/pubmed/?term=24837058
  18. Addington J., Stowkowy J., Weiser M. (2014) Screening Tools for Clinical High Risk for Psychosis. Early Intervention in Psychiatry, 2014 Oct 23. PMID:25345316   http://www.ncbi.nlm.nih.gov/pubmed/?term=25345316
  19. Callaway D.A., Perkins D.O., Woods S.W., Liu L. & Addington J. (2014) Movement abnormalities predict transitioning to psychosis in individuals at clinical high risk for psychosis. Schizophrenia Research, 2014 Nov; 159(2-3):263-6. PMID:25311779   http://www.ncbi.nlm.nih.gov/pubmed/?term=25311779
  20. Trotman H.D., Holtzman C.W., Walker E.F., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Heinssen R.K., Mathalon D.H., Tsuang T.T., Perkins D.O., Deidman L.J., Woods S.W., McGlashan T.H. (2014) Stress Exposure and Sensitivity in the Clinical High Risk Syndrome: Initial Findings from the North American Prodrome Longitundinal Study (NAPLS). Schizophrenia Research, 2014 Dec; 160(1-3):104-9. PMID:25443665   http://www.ncbi.nlm.nih.gov/pubmed/?term=25443665

2013

  1. Addington J. (2013) Identifying a treatable psychosis-risk cohort. Canadian Journal of Psychiatry, 2013 Jan; 58(1):3-4. PMID 23327749  http://www.ncbi.nlm.nih.gov/pubmed/?term=23327749
  2. Fusar-Poli P., Borgwardt S., Bechdolf A., Addington J., Riecher-Rössler A., Schultze-Lutter F. et al. (2013) The Psychosis High Risk State: A Comprehensive State-of-the-Art Review. JAMA Psychiatry, 2013 Jan; 70(1):107-20. PMID: 23165428  http://www.ncbi.nlm.nih.gov/pubmed/?term=23165428
  3. Magaud E., Nyman K. & Addington J. (2013) Cyberbullying in those at Clinical High Risk for psychosis. Early Intervention in Psychiatry, 2013 Nov; 7(4):427-30. PMID:23343259  http://www.ncbi.nlm.nih.gov/pubmed/?term=23343259
  4. Addington J., Stowkowy J., Cadenhead K.S., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W. & Cannon T.D. (2013)  Early traumatic experiences in those at clinical high risk for psychosis.  Early Intervention in Psychiatry, 2013 Aug; 7(3):300-5. PMID: 23343384 http://www.ncbi.nlm.nih.gov/pubmed/?term=23343384
  5. Suridjan I., Rusjan P., Addington J., Wilson A.A., Houle S. & Mizrahi R. (2013) Dopamine D2 and D3 binding in clinical high risk for schizophrenia, antipsychotic naïve and healthy controls while performing a cognitive task. Journal of Psychiatry and Neuroscience, Journal of Psychiatry and Neuroscience, 2013 Mar; 38(2):98-106. PMID: 23010256  http://www.ncbi.nlm.nih.gov/pubmed/?term=23010256
  6. Barbato M., Penn D.L., Perkins D.O., Woods S.W., Liu L. & Addington J. (2013) Metacognitive Functioning in Individuals at Clinical High Risk for Psychosis. Behavioural and Cognitive Psychotherapy, 42(5):526-34. PMID: 23517866. http://www.ncbi.nlm.nih.gov/pubmed/?term=23517866
  7. Walder D., Holtzman C., Addington J., Cadenhead K., Tsuang M., Cornblatt B., Cannon T., McGlashan T., Woods S., Perkins D., Seidman L., Heinssen R. & Walker E.F. (2013) Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome. Schizophrenia Research, 2013 Mar; 144(1-3):43-50. PMID: 23340377  http://www.ncbi.nlm.nih.gov/pubmed/?term=23340377
  8. Stowkowy J. & Addington J. (2013) Predictors of clinical high risk status among individuals with a family history of psychosis. Schizophrenia Research, 2013 Jul; 147(2-3):281-6. PMID: 23611242  http://www.ncbi.nlm.nih.gov/pubmed/?term=23611242
  9. Walker E.F., Trotman H.D., Pearce B.D., Addington J. ,Cadenhead K.S., Cornblatt B.A., Heinssen R., Mathalon D.H., Perkins D.O., Seidman L.J., Tsuang M.T., Cannon T.D., McGlashan T.H. & Woods S.W. (2013) Cortisol levels and risk for psychosis: Initial findings from the North American Prodrome Study. Biological Psychiatry, 2013 Sep 15; 74(6):410-7. PMID: 23562006 http://www.ncbi.nlm.nih.gov/pubmed/?term=23562006
  10. Barbato M., Colijn M.A., Keefe R.S., Perkins D.O., Woods S.W., Hawkins K.A., Christensen B.K. & Addington J. (2013) The course of cognitive functioning over six months in individuals at clinical high risk for psychosis. Psychiatry Research, 2013 Apr 30; 206(2-3):195-9. PMID: 23159196  http://www.ncbi.nlm.nih.gov/pubmed/?term=23159196
  11. Addington D., Patten S., McKenzie E. & Addington J. (2013) Relationship between Relapse and Hospitalization in First-Episode Psychosis. Psychiatric Services, 2013 Aug 1; 64(8):796-9. PMID: 23632466 http://www.ncbi.nlm.nih.gov/pubmed/?term=23632466
  12. Tarbox S.I., Addington J., Cadenhead S., Cannon T.D., Cornblatt B.A., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Heinssen R., McGlashan T.H. & Woods S.W. (2013) Premorbid functional development and conversion to psychosis in clinical high-risk youth. Development and Psychopathology 2013 Nov; 25(4 Pt 1):1171-86. PMID:24229556 http://www.ncbi.nlm.nih.gov/pubmed/?term=24229556
  13. Woods S., Addington J., Bearden C., Cadenhead K.S., Cannon T., Cornblatt B., Mathalon D.H., Perkins D., Seidman L., Tsuang M., Walker E. & McGlashan T. (2013) Psychotropic Medication Use in Youth at High Risk for Psychosis: Comparison of Baseline Data from Two Research Cohorts 1998-2005 and 2008-2011. Schizophrenia Research, 2013 Aug; 148(1-3):99-104 PMID: 23787224        http://www.ncbi.nlm.nih.gov/pubmed/?term=23787224
  14. Cadenhead K.S., Addington J., Cannon T., Cornblatt B., de la Fuente-Sandoval C., Mathalon D., Perkins D., Seidman L., Tsuang M., Walker E., Woods S., Bachman P., Belger A., Carrión R.E., Donkers F., Duncan E., Johannesen J., León-Ortiz P., Light G., Mondragón A., Niznikiewicz M., Nunag J., Roach B.J., Solís-Vivanco R. & the NAPLS Consortium (2013) Between Site Reliability of Startle Prepulse Inhibition Across Two Early Psychosis Consortia Running Head: Between Site Reliability of Startle PPI. NeuroReport,  2013 Aug 7; 24(11):626-30. PMID:23799460 http://www.ncbi.nlm.nih.gov/pubmed/?term=23799460
  15. Barbato M., Liu L., Penn D.L., Keefe R.S.E., Perkins D.O., Woods S.W. & Addington J. (2013) Social Cognition as a Mediator between Neurocognition and Functional Outcome in Individuals at Clinical High Risk for Psychosis. Schizophrenia Research, 2013 Nov; 150(2-3):542-6. PMID: 24012459  http://www.ncbi.nlm.nih.gov/pubmed/?term=24012459
  16. Deighton S., Addington J. (2013) Exercise practices in individuals at clinical high risk of developing psychosis. Early Intervention in Psychiatry, 9(4):284-91. PMID:24252093  http://www.ncbi.nlm.nih.gov/pubmed/?term=24252093
  17. Barbato M.Addington J. (2013) Binocular Depth Perception in Individuals at Clinical High Risk for Psychosis: no evidence of dysfunction. Neuropsychology, 28(3):366-72 PMID:24188117 http://www.ncbi.nlm.nih.gov/pubmed/?term=24188117
  18. Tarbox S. I., Addington J., Cadenhead K., Cannon T. D., Cornblatt B., Perkins D., Seidman L.J., Tsuang M. T., Walker E., Heinssen R., McGlashan T., Woods S. W. (2013) Functional Development in Clinical High Risk Youth: Prediction of Schizophrenia versus other Psychotic Disorders. Psychiatry Research, 215(1):52-60.  PMID: 24200216 http://www.ncbi.nlm.nih.gov/pubmed/?term=24200216
  19. Healey K.M., Penn D.L., Perkins D., Woods S.W., Addington J. (2013) Theory of mind and social judgments in people at clinical high risk of psychosis. Schizophrenia Research, 2013 Nov; 150(2-3):498-504. PMID: 24055202  http://www.ncbi.nlm.nih.gov/pubmed/?term=24055202

2012

  1. Stowkowy, J., Addington, D., Liu, L., Hollowell, B. & Addington, J. (2012) Predictors of   Disengagement from Treatment in an Early Psychosis Program. Schizophrenia Research, 136, 7-12. PMID: 22336955 http://www.ncbi.nlm.nih.gov/pubmed/?term=22336955
  2. Addington, J. & Lecomte, T. (2012) Cognitive Behavior Therapy for Psychosis. F1000 Medicine Reports, 4, 6. PMID: 22403587, PMCID: PMC3292287. http://www.ncbi.nlm.nih.gov/pubmed/?term=22403587
  3. Boydell, K., Volpe, T., Gladstone, B., Stasiulis, E. & Addington, J. (2012) Youth and Ultra High Risk for Psychosis, Using the Revised Network Episode Model to Examine Pathways to Mental Health Care. Early Intervention in Psychiatry, 7, 170-186. PMID: 22390350 http://www.ncbi.nlm.nih.gov/pubmed/?term=22390350
  4. Piskulic, D., Addington, J., Cadenhead, K., Cannon, T., Cornblatt, B., Heinssen, R., Perkins, D., Seidman, L., Tsuang, M., Walker, E., Woods, S., & McGlashan, T, (2012) Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Research, 196, 220-224. PMID: 22445704 http://www.ncbi.nlm.nih.gov/pubmed/?term=22445704
  5. Brummitt, K. & Addington, J. (2012) Treatment Possibilities for Individuals at Clinical High Risk of Psychosis.  Early Intervention in Psychiatry, 7, 155-161. PMID: 22741811  http://www.ncbi.nlm.nih.gov/pubmed/?term=22741811
  6. Stowkowy, J., Colijn, M. & Addington, J. (2012) Pathways to Care for those at Clinical High Risk of Developing Psychosis. Early Intervention in Psychiatry, 7, 80-83. PMID: 22741608  http://www.ncbi.nlm.nih.gov/pubmed/?term=22741608
  7. Marshall, C., Falukozi, E., Albertin, M., Zhu, H., & Addington, J. (2012). The development of the content of attenuated positive symptoms codebook for those at clinical high risk of psychosis. Psychosis: Psychological, Social and Integrative Approaches, 4,191-202.
  8. Addington, J., Piskulic, D., Perkins, D.O., Woods, S.W., Liu, L. & Penn, D.L. (2012) Affect Recognition in People at Clinical High Risk of Psychosis. Schizophrenia Research, 140, 87-92. PMID: 22763425 http://www.ncbi.nlm.nih.gov/pubmed/?term=22763425
  9. Addington, J., McGregor, L., Marulanda D., & Raedler, T. (2012) Recruitment strategies for the detection of individuals at clinical high risk of developing psychosis. Epidemiology and Psychiatric Sciences, 31,1-5. PMID: 23114021 http://www.ncbi.nlm.nih.gov/pubmed/?term=23114021
  10. Yung, A.R., Woods, S.W., Ruhrmann, S., Addington, J., Schultze-Lutter, F., Cornblatt, B.A. et al., (2012) Wither the attenuated psychosis syndrome? Schizophrenia Bulletin, 38, 1130-4. PMID: 23144056 http://www.ncbi.nlm.nih.gov/pubmed/?term=23144056
  11. Addington J. (2012) International Early Psychosis Association, Early Intervention in Psychiatry, 6, 355-6. PMID: 23107577 http://www.ncbi.nlm.nih.gov/pubmed/?term=23107577
  12. Addington, J., Cadenhead, K.S., Cornblatt, B.A, Mathalon, D.H., McGlashan, T.H., Perkins, D.O., Seidman, L.J., Tsuang, M.T., Walker, E.F., Woods, S.W., Addington, J.A. & Cannon, T.D. ( 2012) North American Prodrome Longitudinal Study (NAPLS 2): Overview and recruitment. Schizophrenia Research, 142, 77-82. PMID: 23043872  http://www.ncbi.nlm.nih.gov/pubmed/?term=23043872
  13. Addington J., Marshall, C. & French P. (2012) Cognitive behavioral therapy in prodromal psychosis. Current Pharmaceutical Design, 18, 558-65. PMID: 22239588 http://www.ncbi.nlm.nih.gov/pubmed/?term=22239588
  14. Magaud, E. Marshall, C., Mancuso, E. & Addington, J. (2012). Use of the Self-Esteem Rating Scale—Short Form in a first episode of psychosis sample. Schizophrenia Research, 143, 399-400. PMID: 23265776  http://www.ncbi.nlm.nih.gov/pubmed/?term=23265776
  15. Barbato, M. & Addington, J. The role of cognitive functioning in the outcome of those at clinical high risk of psychosis (2012) Epidemiology and Psychiatric Sciences, 4), 335-42. PMID:23159196, PMCID: PMC3600156 http://www.ncbi.nlm.nih.gov/pubmed/?term=23159196
  16. Falukozi E. & Addington J. (2012) Impact of trauma on attenuated psychotic symptoms. Psychosis: Psychological, Social and Integrative Approaches, 2012; 4(3):203-212. PMID: 23155365 http://www.ncbi.nlm.nih.gov/pubmed/?term=23155365

2011

  1. Addington, J. & Piskulic, D. (2011). Social cognition and functional outcome are separate domains in schizophrenia. Schizophrenia Research, 127, 262-263. PMID: 20471225 http://www.ncbi.nlm.nih.gov/pubmed/?term=20471225
  2. Addington, J., Epstein, I., Liu, L., French, P., Boydell, K.M. & Zipursky, R.B. (2011).  A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophrenia Research, 125, 54-61, PMID: 21074974  http://www.ncbi.nlm.nih.gov/pubmed/?term=21074974
  3. Piskulic, D, & Addington, J., Arthur, A. & Cornblatt, B.A. (2011) Using the global functioning social and role scales in a first-episode sample. Early Intervention in Psychiatry, 5, 219-223, PMID: 21481198 http://www.ncbi.nlm.nih.gov/pubmed/?term=21481198
  4. Addington, J., Cornblatt, B., Cadenhead, K., Cannon, T., McGlashan, T., Perkins, D., Seidman, L Tsuang, M., Walker, E., Woods, S. &. Heinssen, R. (2011). At clinical high risk for psychosis: outcome for the non-converters. American Journal of Psychiatry, 168, 800-805. PMID: 21498462 http://www.ncbi.nlm.nih.gov/pubmed/?term=21498462
  5. Piskulic, D. & Addington, J. (2011). Social cognition and negative symptoms in psychosis. Psychiatric Research, 188, 283-285, PMID: 21571376 http://www.ncbi.nlm.nih.gov/pubmed/?term=21571376
  6. Menon, M., Addington, J. & Remington, G. (2011) Examining cognitive biases in patients with delusions of reference. European Psychiatry, 28:71-3. PMID:21658918 http://www.ncbi.nlm.nih.gov/pubmed/?term=21658918
  7. Stowkowy, J. & Addington, J. (2011). Maladaptive schemas as a mediator between social defeat and positive symptoms in young people at clinical high risk for psychosis. Early Intervention in Psychiatry, 168, 800-5. PMID:21951894 http://www.ncbi.nlm.nih.gov/pubmed/?term=21951894
  8. Marshall, C., Addington, J., Epstein, I., Liu, L., Deighton, S. & Zipursky, R.B. (2011) Treating Young Individuals at Clinical High Risk for Psychosis. Early Intervention in Psychiatry, 6, 60-8. PMID: 21951980 http://www.ncbi.nlm.nih.gov/pubmed/?term=21951980
  9. Gee, D.G., Karlsgodt, K.H., van Erp, T.G., Bearden, C.E., Lieberman, M.D., Belger, A., Perkins, D.O., Olvet, D.M., Cornblatt, B.A., Constable, T., Woods, S.W., Addington, J., Cadenhead, K.S., McGlashan, T.H., Seidman, L.J., Tsuang, M.T., Walker, E.F. & Cannon, T.D. (2011) Altered age-related trajectories of amygdala-prefrontal circuitry in adolescents at clinical high risk for psychosis: a preliminary study. Schizophrenia Research, 134, 1-9. PMID:  22056201  http://www.ncbi.nlm.nih.gov/pubmed/?term=22056201
  10. Cornblatt, B., Carrion, R.F.  Addington, J., Seidman, L., Walker, E., Cannon, T., Cadenhead, K., McGlashan, T., Perkins, D., Tsuang, M., Woods, S., Heinssen, R. & Lencz, T. (2011). Risk factors for psychosis: Impaired social and role functioning. Schizophrenia Bulletin, 38:1247-57.  PMID: 22080497  http://www.ncbi.nlm.nih.gov/pubmed/?term=22080497
  11. Mizrahi, R., Addington, J., Rusjan, P.M., Suridjan, I., Nq, A., Boileau, I., Pruessner, J.C., Remington, G., Houle, S. & Wilson, A.A. (2011). Increased stress-induced dopamine release in psychosis. Biological Psychiatry, 71, 561-567. PMID:22133268 http://www.ncbi.nlm.nih.gov/pubmed/?term=22133268
  12. Addington, J. & Heinssen, R. (2011) Prediction and prevention of psychosis in youth at clinical high risk. Annual Review of Clinical Psychology, 8, 269-289. PMID: 22224837  http://www.ncbi.nlm.nih.gov/pubmed/?term=22224837
  13. Menon, M., Schmitz, T.W., Anderson, A.K., Graff, A., Korostil, M., Mamo, D., Gerretsen, P., Addington, J., Remington, G. & Kapur, S. (2011) Exploring the neural correlates of delusions of reference. Biological Psychiatry, 70, 1127-33. PMID:21831358 http://www.ncbi.nlm.nih.gov/pubmed/?term=21831358

2010

  1. Addington, J., Piskulic, D., & Marshall, C. (2010). Psychosocial treatments for schizophrenia . Current Directions in Psychological Science, 19, 260-263.
    http://cdp.sagepub.com/content/19/4/260.full
  2. Cadenhead, K.S., Addington, J., Cannon, T.D., Cornblatt, B.A McGlashan, T., Perkins, D.O., Seidman. L., Tsuang, M.T., Walker, E.F., Woods, S., & Heinssen, R. (2010). Treatment history in the psychosis prodrome: Characteristics of the North American Prodrome Longitudinal Study Cohort. Early Intervention in Psychiatry, 4, 220-226.
    http://www.ncbi.nlm.nih.gov/pubmed/20712727
  3. Seidman. L., Giuliano, A.J., Meyer, A.C., Addington, J., Cadenhead, K.S., Cannon, T.D., McGlashan, T., Perkins, D.O., Tsuang, M.T., Walker, E.F., Woods, S., Bearden, C.E., Christensen, B.K., Hawkins, K., Heaton, R., Keefe, R.S.E., Heinssen, R., & Cornblatt, B.A. (2010). Neuropsychology of the prodrome to psychosis in the NAPLS consortium: Relationship to family history and conversion to psychosis. Archives of General Psychiatry, 67, 578-588.
    http://www.ncbi.nlm.nih.gov/sites/entrez/20530007
  4. Addington, J., Girard, T.A., Christensen, B.K., & Addington, D. (2010). Social cognition mediates illness related and cognitive influences on social functioning in schizophrenia-spectrum disorders. Journal of Psychiatry and Neuroscience, 35, 49-54.
    http://www.ncbi.nlm.nih.gov/sites/entrez/20530007
  5. McGorry, P., Johanessen, J.O., Lewis, S., Birchwood, M., Malla, A. Nordentoft, M., Addington, J., & Yung, A. (2010). Early intervention in psychosis: Keeping faith with evidence based health care. Psychological Medicine, 40, 399-404.
    http://www.ncbi.nlm.nih.gov/pubmed/19775497

2009

  1. Addington, J., & Addington, D. (2009). Three year outcome of treatment in an early psychosis program. Canadian Journal of Psychiatry, 54, 626-630.
    http://www.ncbi.nlm.nih.gov/pubmed/19751551
  2. Walker, E., Cornblatt, C., Addington, J., Cadenhead, K., Cannon, T.D., McGlashan, T.H., Perkins, D.O., Seidman, L.J., Tsuang, M., Woods, S.W., & Heinssen, R. (2009). The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: A naturalistic study of the North American Prodrome Longitudinal Sample. Schizophrenia Research, 115, 50-57.
    http://www.ncbi.nlm.nih.gov/pubmed/19709859
  3. Addington, J., & Mancuso, E. (2009). Cognitive-behavioral therapy for individuals at high risk of developing psychosis. Journal of Clinical Psychology, 65, 879-890.
    http://www.ncbi.nlm.nih.gov/pubmed/19536867
  4. Woods, S.W., Addington, J., Cadenhead, K.S., Cannon, T.D., Cornblatt, B.A., Heinssen, R. Perkins, D.O., Seidman, L.J., Tsuang, M.T., Walker, E.F., & McGlashan, T.H. (2009). Prodromal risk syndrome for first psychosis. Schizophrenia Bulletin, 35, 894-908.
    http://www.ncbi.nlm.nih.gov/pubmed/19386578
  5. Addington, J., & Tran, L. (2009). Using the brief core schema scales with individuals at clinical high risk of psychosis. Behavioral and Cognitive Therapy, 37, 227-231.
    http://www.ncbi.nlm.nih.gov/pubmed/19364422

2008

  1. Addington, J., & Addington, D. (2008). Symptom remission in first episode patients. Schizophrenia Research, 106, 281-285.
    http://www.ncbi.nlm.nih.gov/pubmed/18926666
  2. Addington, J., & Addington, D. (2008). Outcome after discharge from an early psychosis program. Schizophrenia Research, 106, 363-366.
    http://www.ncbi.nlm.nih.gov/pubmed/18829260
  3. Hawkins, K.A., Keefe, R.S., Christensen, B.J., Addington, J., Woods, S.W., Callahan, J., Zipursky, R.B., Perkins, D.O., Tohen, M., Breier, A., & McGlashan, T.H. (2008). Neuropsychological course in the prodrome and first episode of psychosis: Findings from the PRIME North American Double Blind Treatment Study. Schizophrenia Research, 105, 1-9.
    http://www.ncbi.nlm.nih.gov/pubmed/18774696
  4. Pencer, A., & Addington, J. (2008). Models of substance use in adolescents with and without psychosis. Journal of the Canadian Academy of Child & Adolescent Psychiatry, 17, 202-209.
    http://www.ncbi.nlm.nih.gov/pubmed/19018323
  5. Compton, M.T., Goulding, S.M., Ramsay, C.E., Addington, J., Corcoran, C., & Walker, E. (2008). Early detection and intervention for psychosis: Perspectives from North America. Clinical Neuropsychiatry, 5, 263-272.
    http://www.clinicalneuropsychiatry.org/pdf/02_compton.pdf
  6. Mizrahi, R., Addington, J., Remington, G., & Kapur, S. (2008). Attribution style as a factor in psychosis and symptom resolution. Schizophrenia Research, 104, 220-227.
    http://www.ncbi.nlm.nih.gov/pubmed/18632256
  7. Addington. J., Epstein, I., Reynolds, A., Furimsky, I., Rudy, L., Mancini, B., McMillan, S., Kirsopp, D., & Zipursky, R.B. (2008). Early detection of psychosis: Finding those at clinical high risk. Early Intervention in Psychiatry, 2, 147-153.
    http://onlinelibrary.wiley.com/doi/10.1111/j.1751-7893.2008.00078.x/abstract
  8. Weiser, M., Reichenberg, A., Werbeloff, N., Kravits, E., Halperin, D., Lubin, G., Shmushkevitch, M., Yoffe, R., Addington, J., Davidson, M. (2008). Self-report of family functioning and risk for psychotic disorders in male adolescents with behavioral disturbances. Acta Psychiatrica Scandinavica, 117, 225-231.
    http://www.ncbi.nlm.nih.gov/pubmed/18241305
  9. Couture, S.M., Penn, D.L., Addington, J., Woods, S.W., & Perkins, D.O. (2008). Assessment of social judgments and complex mental states in the early phases of psychosis. Schizophrenia Research, 100, 237-241.
    http://www.ncbi.nlm.nih.gov/pubmed/18255273
  10. Addington, J., Penn, D.L., Woods, S.W., Addington, D., & Perkins, D.O. (2008). Social functioning in individuals at clinical high risk for psychosis. Schizophrenia Research, 99, 119-124.
    http://www.ncbi.nlm.nih.gov/pubmed/18023329
  11. Addington, J., Penn, D.L., Woods, S.W., Addington, D., & Perkins, D.O. (2008). Facial affect recognition in individuals at clinical high risk for psychosis. British Journal of Psychiatry, 192, 67-68.
    http://www.ncbi.nlm.nih.gov/pubmed/18174514
  12. Cannon, T.D., Cadenhead, K., Cornblatt, C., Woods, S.W., Addington, J., Walker, E., Seidman, L.J., Perkins, D.O., Tsuang, M., McGlashan, T.H., & Heinssen, R. (2008). Prediction of psychosis in youth at clinical high risk: A multi-site longitudinal study in North America. Archives of General Psychiatry, 65, 28-37.
    http://www.ncbi.nlm.nih.gov/pubmed/18180426
  13. Addington J. & Addington, D.E. (2008). Social and cognitive functioning in psychosis. Schizophrenia Research, 99, 176-181.
    http://www.ncbi.nlm.nih.gov/pubmed/17681756
  14. Addington, J. (2008). The promise of early intervention. Early Intervention in Psychiatry, 1, 294-307.
    http://onlinelibrary.wiley.com/doi/10.1111/j.1751-7893.2007.00043.x/abstract

2007

  1. Hoffman, R.E., Woods, S.W., Hawkins, K.A., Pittman, B., Tohen, M., Preda, A., Breier, A., Glist, J., Addington, J., Perkins, D.O., McGlashan, T.H. (2007). Extracting spurious messages from noise and risk of schizophrenia-spectrum disorders in a prodromal population. British Journal of Psychiatry, 191, 355-356.
    http://www.ncbi.nlm.nih.gov/pubmed/17906248
  2. Dutta, R., Greene, T., Addington, J., McKenzie, K., Phillips, M., & Murray, R.M. (2007). Biological, life course, and cross-cultural studies all point towards the value of dimensional and developmental ratings in the classification of psychosis. Schizophrenia Bulletin, 33, 868-876.
    http://www.ncbi.nlm.nih.gov/pubmed/17562692
  3. McCleery, A., Addington, J., & Addington, D. (2007). Family assessment in early psychosis. Psychiatry Research, 152, 95-102.
    http://www.ncbi.nlm.nih.gov/pubmed/17449111
  4. Addington, D., McKenzie, E., Addington, J., Patten, S., Smith H., & Adair, C. (2007). Performance measures for evaluating services for people with a first episode of psychosis. Early Intervention in Psychiatry, 1, 157-167.
    http://onlinelibrary.wiley.com/doi/10.1111/j.1751-7893.2007.00020.x/full
  5. McGlashan, T.H., Addington, J., Cannon, T., Heinimaa, M., McGorry, P., O'Brien, M., Penn, D., Perkins, D., Salokangas, R.K., Walsh, B., Woods, S.W., & Yung, A. (2007). Recruitment and treatment practices for help-seeking "prodromal" patients. Schizophrenia Bulletin, 33, 715-726.
    http://www.ncbi.nlm.nih.gov/pubmed/17483100
  6. Addington, J., Mancuso, E., & Haarmans, M. (2007). Cognitive behaviour therapy and early intervention. The Journal of the Norwegian Psychological Association, 6, 573-580.
  7. Addington, J., Cadenhead, K.S. Cannon, T.D., Cornblatt, B., McGlashan, T.H., Perkins, D.O., Seidman, L.J., Tsuang, M., Walker, E.F., Woods, S.W., & Heinssen, R. (2007). North American Prodrome Longitudinal Study: A collaborative multi-site approach to prodromal schizophrenia research. Schizophrenia Bulletin, 33, 665-672.
    http://www.ncbi.nlm.nih.gov/pubmed/17255119
  8. Addington, J., & Addington, D. (2007). Patterns, predictors and impact of substance use in early psychosis: A longitudinal study. Acta Psychiatrica Scandinavica, 115, 304-309.
    http://www.ncbi.nlm.nih.gov/pubmed/17355521
  9. Saeedi, H., Addington, J., & Addington, D. (2007). The association of insight with psychotic symptoms, depression and cognition in early psychosis: A 3 year follow-up. Schizophrenia Research, 89, 123-128. http://www.ncbi.nlm.nih.gov/pubmed/17097272

2006

  1. Addington, D., Addington, J., and Patten, S. (2006). Relapse Rates in an Early Psychosis Treatment Service. Acta Psychiatrica Scandinavica, 115, 126-131.
    http://www.ncbi.nlm.nih.gov/pubmed/17244176
  2. McCleery, A., Addington, J., & Addington D. (2006). Substance misuse and cognitive functioning in early psychosis: A 2 year follow-up. Schizophrenia Research, 88, 187-191.
    http://www.ncbi.nlm.nih.gov/pubmed/16942863
  3. Pierson, K., Addington, D., Addington, J., & Patten, S. (2006). Serum Monitoring in Antipsychotic Drug Levels During Concomitant Administration of Sertraline and Antipsychotic Medication. Canadian Journal of Psychiatry, 51, 715-718.
    http://www.ncbi.nlm.nih.gov/pubmed/17121171
  4. Addington, J., Saeedi, H., & Addington, D. (2006). Weight gain in early psychosis over three years. Schizophrenia Research, 86, 335-336.
    http://www.ncbi.nlm.nih.gov/pubmed/16887336
  5. Addington, J., Saeedi, H., & Addington, D. (2006). Influence of social perception and social knowledge on cognitive and social functioning in early psychosis. British Journal of Psychiatry, 189, 373-378.
    http://www.ncbi.nlm.nih.gov/pubmed/17012662
  6. Chaves, A.C., Addington, J., Seeman, M. & Addington, D. (2006). One year stability of diagnosis in first episode non-affective psychosis: Influence of sex. Canadian Journal of Psychiatry, 51, 711-714.
    http://www.ncbi.nlm.nih.gov/pubmed/17121170
  7. Addington, J., Chaves, A.C., & Addington, D. (2006). Diagnostic stability over one year in first-episode psychosis. Schizophrenia Research, 86, 71-75.
    http://www.ncbi.nlm.nih.gov/pubmed/16750610
  8. Addington, J., Saeedi, H., & Addington, D. (2006). Facial affect recognition: A mediator between cognitive and social functioning in psychosis? Schizophrenia Research, 85, 142-150.
    http://www.ncbi.nlm.nih.gov/pubmed/16678388
  9. Addington, J., & Addington, D. (2006). Early intervention for psychosis: who refers? Schizophrenia Research, 84, 176-177.
    http://www.ncbi.nlm.nih.gov/pubmed/16546354
  10. McGlashan, T.H., Zipursky, R.B., Perkins, D., Addington, J., Miller, T., Woods, S., Hawkins, K., Hoffman, R., Preda, A., Epstein, I., Addington, D., Lindborg, S., Trzaskoma, Q., Tohen, M., & Breier, A. (2006). The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis: Efficacy and safety results of the bouble-blind and no-treatment follow-up periods. American Journal of Psychiatry, 163, 790-799.
    http://www.ncbi.nlm.nih.gov/pubmed/16648318
  11. Addington, J., & Haarmans, M. (2006). Cognitive-behavioural therapy for individuals recovering from a first episode of psychosis. Contemporary Psychotherapy, 36, 43-49.
    http://www.springerlink.com/content/v37035m445n64751/
  12. Addington, J., McCleery, A., Collins, A., & Addington, D. (2006). Family work in early psychosis. Journal of Family Psychotherapy, 17, 137-153.
    http://www.informaworld.com/smpp/content~db=all~content=a902889756

2005

  1. Addington, D., McKenzie, E., Addington, J., Patten, S., Smith H., & Adair, C. (2005). Performance measures for early psychosis treatment services. Psychiatric Services, 56, 1570-1582.
    http://www.ncbi.nlm.nih.gov/pubmed/16339620
  2. Addington, J., McCleery, A., & Addington, D. (2005). Three year outcome of family work in an early psychosis program. Schizophrenia Research, 79, 107-116.
    http://www.ncbi.nlm.nih.gov/pubmed/15907375
  3. Addington, J., Collins, A., McCleery, A., & Addington, D. (2005). The role of family work in early psychosis. Schizophrenia Research, 79, 77-83.
    http://www.ncbi.nlm.nih.gov/pubmed/16198240
  4. Addington, J. (2005). 4th International Conference on Early Psychosis: 'Translating the evidence'. Schizophrenia Research, 79, 1-4.
  5. Addington, J., Saeedi, H., & Addington, D. (2005). The course of cognitive functioning in first episode psychosis: Changes over time and impact on outcome. Schizophrenia Research, 78, 35-43.
    http://www.ncbi.nlm.nih.gov/pubmed/15978781
  6. Addington, J., & Gleeson, J. (2005). Implementing cognitive-behavioural therapy for first-episode psychosis. British Journal of Psychiatry, 187 (Suppl. 48), 72-276.
    http://www.ncbi.nlm.nih.gov/pubmed/16055812
  7. Addington, J., & Addington, D. (2005). Clinical trials in the prodromal stage of schizophrenia psychosis: Who consents? [Letter to the editor]. American Journal of Psychiatry, 162, 1387.
    http://www.ncbi.nlm.nih.gov/pubmed/15994732
  8. Voges, M., & Addington, J. (2005). The association between social anxiety and social functioning in first episode psychosis. Schizophrenia Research, 76, 287-292.
    http://www.ncbi.nlm.nih.gov/pubmed/15949660
  9. Addington, J., & Addington, D. (2005). Patterns of premorbid functioning in first episode psychosis: Relationship to 2-year outcome. Acta Psychiatrica Scandinavica, 112, 40-46.
    http://www.ncbi.nlm.nih.gov/pubmed/15952944
  10. Pencer A., Addington, J., & Addington D. (2005). Outcome of a first episode of psychosis in adolescence: A 2-year follow-up. Psychiatry Research, 133, 35-43.
    http://www.ncbi.nlm.nih.gov/pubmed/15698675

2004

  1. Van Mastrigt, S., Addington, J., & Addington, D. (2004). Substance misuse at presentation to an early psychosis program. Social Psychiatry and Psychiatric Epidemiology, 39, 69-72.
  2. Mintz, A.R., Addington, J., & Addington D. (2004). Insight in early psychosis: A one year follow-up. Schizophrenia Research, 67, 213-217.
  3. Hawkins, K.A., Quinlan, D., Miller, T.J., Woods, S.W., Perkins, D.O., Zipursky, R.B., Addington, J., & McGlashan, T.H. (2004). Factorial structure of the scale of prodromal symptoms. Schizophrenia Research, 68, 339-347.
  4. Hawkins, K.A., Addington, J., Keefe, R.S., Christensen, B., Perkins, D.O., Zipursky, R., Woods, S.W., Miller, T.J., Narqueez, E., Breier, A., & McGlashan, T.H. (2004). Neuropsychological status of subjects at high risk for a first episode of psychosis. Schizophrenia Research, 67,115-122.
  5. Addington, J., Williams, J., Young, J. & Addington, D. (2004). Suicidal behaviour in early psychosis. Acta Psychiatrica Scandinavica, 109, 116-120.
  6. Addington, J., Van Mastrigt, S., & Addington, D. (2004). Duration of untreated psychosis: Impact on one and two year outcome. Psychological Medicine, 34, 277-284.
  7. Addington, J. (2004). The diagnosis and assessment of individuals prodromal for schizophrenic psychosis. CNS Spectrum, 9, 588-594.

2003

  1. Woods, S.W., Breier, A., Zipursky, R.B., Perkins, D.O., Addington, J., Miller, T.J., Hawkins, K.A., Marquez, E., David, S.R., Tohen, M., & McGlashan, T.H. (2003). Randomized trial of olanzapine versus placebo in the symptomatic treatment of patients meeting criteria for the schizophrenic prodrome. Biological Psychiatry, 54, 453-464.
  2. Quillams, L., & Addington, J. (2003). Beliefs about illness, insight and knowledge in first episode psychosis [Letter to the Editor]. Canadian Journal of Psychiatry, 48, 350.
  3. Pencer, A., & Addington, J. (2003). Substance abuse and cognition in early psychosis. The Journal of Psychiatry & Neuroscience, 28, 48-54.
  4. Miller, T.J., Zipursky, R.B., Perkins, D.O., Addington, J., Woods, S.W., Hawkins, K.A., Hoffman, R., David, S., Tohen, M., Breier, A., & McGlashan, T.H. (2003). A randomized double blind clinical trial of olanzapine versus placebo in patients at risk for being prodromally symptomatic for psychosis: II. Recruitment and baseline characteristics of the prodromal sample. Schizophrenia Research, 61, 19-30.
  5. McGlashan, T.H., Zipursky, R.B., Perkins, D.O., Addington, J., Miller, T.J., Woods, S.W., Hawkins, K.A., Hoffman, R., David, S., Tohen, M., & Breier, A. (2003). A randomized double blind clinical trial of olanzapine versus placebo in patients at risk for being prodromally symptomatic for psychosis: I. Study rationale and design. Schizophrenia Research, 61, 7-18.
  6. Addington, J., Young, J. & Addington, D. (2003). Social outcome in early psychosis program. Psychological Medicine, 33, 1119-1124.
  7. Addington, J., van Mastrigt, S., & Addington D. (2003). Patterns of premorbid functioning in first episode psychosis: Initial presentation. Schizophrenia Research, 62, 23-30.
  8. Addington, J., Mansley, C., & Addington, D. (2003). Weight gain in early psychosis. Canadian Journal of Psychiatry, 48, 272-276.
  9. Addington, J., Leriger, E., & Addington, D. (2003). Symptom outcome one year after admission to an early psychosis program. The Canadian Journal of Psychiatry, 48, 204-207.
  10. Addington J., Coldham, E., Jones, B., Ko, T., & Addington, D. (2003). The first episode of psychosis: The experience of relatives. Acta Psychiatrica Scandinavica, 108, 285-289.

2002

  1. Addington, J. Brooks, B., & Addington, D. (2002). Cognitive functioning in first episode psychosis: Initial presentation. Schizophrenia Research, 62, 59-64.
  2. Van Mastrigt, S., & Addington, J. (2002). The assessment of premorbid functioning in first episode schizophrenia. The Journal of Psychiatry & Neuroscience, 27, 92-101.
  3. Coldham, E.L., Addington, J., & Addington, D. (2002). Medication adherence of individuals with a first episode of psychosis. Acta Psychiatrica Scandinavica, 106, 286-290.
  4. Addington, J., van Mastrigt, S., Hutchinson, J., & Addington D. (2002). Pathways to Care: Help seeking behavior in first episode psychosis. Acta Psychiatrica Scandinavica, 106, 358-364.
  5. Addington, J., & Addington, D. (2002). Cognitive functioning in first episode schizophrenia. The Journal of Psychiatry & Neuroscience, 27, 188-192.
  6. Addington, D., Addington, J., Patten, S., Remington, G., Moamai, J., Labelle, A., & Beauclair, L. (2002). Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia. Journal of Clinical Psychopharmacology, 22, 20-25.

2001

  1. Martens, L., & Addington, J. (2001). Psychological well being of family members of individuals with schizophrenia. Social Psychiatry and Psychiatric Epidemiology, 36, 128-133.
  2. Grant, C., Addington, J., Addington, D., & Konnert, C. (2001). Social functioning in first & multi-episode schizophrenia. Canadian Journal of Psychiatry, 46, 669-672.
  3. Addington J., Jones, B., Ko, T., & Addington, D. (2001). Family intervention in early psychosis. Psychiatric Rehabilitation Skills, 5, 272-286.
  4. Addington, J., Addington, D., & Gasbarre, L. (2001). Neurocognitive and social functioning in schizophrenia and other diagnoses [Letter to the Editor]. Schizophrenia Research, 48, 367-368.
  5. Addington, J., & Addington, D. (2001). Impact of an early psychosis program on substance use. The Journal of Psychiatric Rehabilitation, 25, 60-67.
  6. Addington, J., & Addington, D. (2001). Impact of an early psychosis program on substance use. The Journal of Psychiatric Rehabilitation, 25, 60-67.
  7. Addington, J., & Addington, D. (2001). Early intervention for psychosis: The Calgary Early Psychosis Treatment & Prevention Program. The Canadian Psychiatric Association Bulletin, 33, 11-16.
  8. Addington, D., & Addington, J. (2001). Depression in schizophrenia. Journal of Advances in Schizophrenia, 3, 121-125.

2000

  1. Addington, J., & Addington, D. (2000). Neurocognitive and social functioning in schizophrenia: A 2.5 year follow-up. Schizophrenia Research, 44, 47-56.

1999

  1. Addington J., el-Guebaly, N., Duchak, V., & Hodgins, D. (1999). Using measures of readiness to change in individuals with schizophrenia. Journal of Drug and Alcohol Abuse, 25, 151-161.
  2. Addington, J., & Addington D. (1999). Neurocognitive and social functioning in schizophrenia. Schizophrenia Bulletin, 25,173-182.
  3. Addington, D., Addington, J., & Robinson, G. (1999). Attributional style and depression in schizophrenia. Canadian Journal of Psychiatry, 44, 697-700.

1998

  1. Addington, J., McCleary, L., & Munroe-Blum, H. (1998). Cognitive and social dysfunction in schizophrenia. Schizophrenia Research, 34, 59-66.
  2. Addington, J., el-Guebaly, N., Addington, D., Campbell, W., & Hodgins, D. (1998). Smoking cessation treatment in schizophrenia. American Journal of Psychiatry, 55, 974-976.
  3. Addington, J., & el-Guebaly, N. (1998). Group treatment for substance abuse in schizophrenia. Canadian Journal of Psychiatry, 43, 843-845.
  4. Addington, J., & Addington D. (1998). Visual attention & symptoms in schizophrenia: A one year follow-up. Schizophrenia Research, 34, 95-99.
  5. Addington, J., & Addington, D. (1998). The effects of substance abuse in early psychosis. British Journal of Psychiatry, 172 (Suppl. 33), 134-136.
  6. Addington, J., & Addington, D. (1998). Facial affect recognition and information processing in schizophrenia and bipolar disorder. Schizophrenia Research, 32, 171-181.
  7. Addington, J. (1998). Group treatment for smoking cessation in schizophrenia. Psychiatric Services, 49, 925-928.
  8. Addington, D., Addington, J., & Patten, S. (1998). Depression in first episode schizophrenia. British Journal of Psychiatry, 172 (Suppl. 33), 90-92.

1997

  1. Addington, J., el-Guebaly, N., Addington, D., & Hodgins, D. (1997). Readiness to stop smoking in schizophrenia. Canadian Journal of Psychiatry, 42, 49-52.
  2. Addington, J., & Duchak, V. (1997). Reasons for substance use in schizophrenia. Acta Psychiatrica Scandinavica, 96, 329-333.
  3. Addington, J., & Addington, D. (1997). Substance abuse and cognitive functioning in schizophrenia. The Journal of Psychiatry & Neuroscience, 22, 99-104.
  4. Addington, J., & Addington, D. (1997). Neurocognitive functioning in schizophrenia: A trial of risperidone versus haloperidol [Letter to the Editor]. The Canadian Journal of Psychiatry, 42, 983.
  5. Addington, J., & Addington, D. (1997). Attentional vulnerability indicators in schizophrenia and bipolar disorder. Schizophrenia Research, 23, 197-204.

1996

  1. Addington, J., & el-Guebaly, N. (1996). Intravenous tripelennamine abuse in schizophrenia [Letter to the Editor]. The Canadian Journal of Psychiatry, 41, 63.
  2. Addington, D., Addington, J., & Patten, S. (1996). Gender and affect in schizophrenia. Canadian Journal of Psychiatry, 41, 265-268.
  3. Addington, D., Addington, J., & Atkinson, M. (1996). A psychometric comparison of the Calgary Depression Scale for Schizophrenia. Schizophrenia Research, 19, 205-212.

1994

  1. Addington, D., Addington, J., & Maticka-Tyndale, E. (1994). Specificity of the Calgary Depression Scale for schizophrenics. Schizophrenia Research, 11, 239-244.

1993

  1. Addington, J., & Addington, D. (1993). Premorbid functioning, cognitive functioning and outcome in schizophrenia. The Journal of Psychiatry & Neuroscience, 18, 18-23.
  2. Addington, D., Addington, J., & Maticka-Tyndale, E. (1993). Rating depression in schizophrenia: A comparison of self-report and an observer report scale. Journal of Nervous and Mental Disease, 181, 561-565.
  3. Addington, D., Addington, J., & Maticka-Tyndale, E. (1993). Assessing depression in schizophrenia: The Calgary Depression Scale. British Journal of Psychiatry, 163 (Suppl. 22), 39-44.

1992

  1. Addington, D., Addington, J., Joyce, J. & Maticka-Tyndale, E. (1992). Reliability and validity of a depression rating scale. Schizophrenia Research, 6, 201-208.
  2. Addington, D., Addington, J., Joyce, J., & Maticka-Tyndale, E. (1992). Reliability and validity of a depression rating scale. Schizophrenia Research, 6, 201-208.

1991

  1. Addington, J., Addington, D., & Maticka-Tyndale, E. (1991). Cognitive functioning and positive and negative symptoms of schizophrenia. Schizophrenia Research, 5, 123-134.
  2. Addington, J., & Addington, D. (1991). Positive and negative symptoms of schizophrenia: Their course and relationship over time. Schizophrenia Research, 5, 51-59.

1990

  1. Addington, D., Addington, J., & Schissel, B. (1990). A depression rating scale for schizophrenics. Schizophrenia Research, 3, 247-251.
  2. Addington, D., & Addington, J. (1990). Depression, negative symptoms, and dexamethasone suppression in schizophrenia. Canadian Journal of Psychiatry, 35, 430-433.